Hilar Cholangiocarcinoma Clinical Trials

3 recruiting

Hilar Cholangiocarcinoma Trials at a Glance

9 actively recruiting trials for hilar cholangiocarcinoma are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Amsterdam, Augsburg, and Berlin. Lead sponsors running hilar cholangiocarcinoma studies include Azienda Ospedaliera di Padova, Azienda Sanitaria Ospedaliera, and Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).

Browse hilar cholangiocarcinoma trials by phase

Treatments under study

About Hilar Cholangiocarcinoma Clinical Trials

Looking for clinical trials for Hilar Cholangiocarcinoma? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hilar Cholangiocarcinoma trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hilar Cholangiocarcinoma clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 2

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

CholangiocarcinomaBile Duct CancerHilar Cholangiocarcinoma
Jinbo Yue38 enrolled1 locationNCT07030140
Recruiting
Not Applicable

LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma (LITALHICA)

Perihilar Cholangiocarcinoma
Azienda Sanitaria Ospedaliera50 enrolled1 locationNCT06125769
Recruiting
Phase 2

PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma

Perihilar Cholangiocarcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University62 enrolled1 locationNCT05430698
Recruiting

A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening

ctDNAGall Bladder CancerIntrahepatic Cholangiocarcinoma (Icc)+3 more
Yingbin Liu, MD, PhD, FACS1,800 enrolled1 locationNCT07176962
Recruiting
Not Applicable

Liver Transplantation for Non-resectable Perihilar Cholangiocarcinoma

Bile Duct CancerPerihilar CholangiocarcinomaKlatskin Tumor
Oslo University Hospital15 enrolled1 locationNCT04993131
Recruiting

Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma

Perihilar CholangiocarcinomaKlatskin Tumor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano8 enrolled1 locationNCT06986486
Recruiting
Phase 4

Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therapy

Hilar Cholangiocarcinoma
University of Leipzig258 enrolled20 locationsNCT05551299
Recruiting

Robotically Assisted Surgery For Perihilar Cholangiocarcinoma: A Prospective Study

Cholangiocarcinoma CancerPerihilar Cholangiocarcinoma
Azienda Ospedaliera di Padova32 enrolled1 locationNCT06720883
Recruiting
Not Applicable

Endobiliary Radiofrequency Ablation for Malignant Biliary Obstruction Due to Perihilar Cholangiocarcinoma

Perihilar Cholangiocarcinoma
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)98 enrolled1 locationNCT05546372